Demographic and socioeconomic factors predictive of compliance with American Thyroid Association guidelines for the treatment for advanced papillary thyroid carcinoma

Ashley E. Wenaas, Celeste Z. Nagy, Yin Yiu, Li Xu, Kelsey Horter, Jose P. Zevallos

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Background The American Thyroid Association (ATA) publishes evidence-based guidelines for the treatment of papillary thyroid carcinoma (PTC). We sought to identify factors associated with receiving treatment compliant with the 2006 ATA guidelines for advanced-stage PTC. Methods The 2006 ATA guideline compliance was examined in patients with stage III and IV PTC extrapolated from Surveillance, Epidemiology, and End Results (SEER). Results Sixty percent of patients received ATA-compliant treatment. A stepwise increase in compliance occurred between 2006 and 2009 (p-value trend =.0003). Age 45 to 64 years versus ≥65 (odds ratio [OR] = 0.682; 95% confidence interval [CI] = 0.57-0.81; p <.0001) and higher income (p trend =.012) were associated with an increased likelihood of receiving ATA-compliant care. African Americans (OR = 0.56; 95% CI = 0.42-0.76; p =.0001) and single patients (OR = 0.81; 95% CI = 0.67-0.97; p =.02) were less likely to receive ATA-compliant care. Conclusion This study highlights specific populations at risk for receiving non-ATA-compliant care for PTC and underscores the need to further implement guideline-based practice.

Original languageEnglish (US)
Pages (from-to)1776-1780
Number of pages5
JournalHead and Neck
Volume37
Issue number12
DOIs
StatePublished - Dec 1 2015

Keywords

  • American Thyroid Association (ATA) guidelines
  • disparities
  • papillary thyroid carcinoma
  • socioeconomic status
  • thyroid cancer

ASJC Scopus subject areas

  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'Demographic and socioeconomic factors predictive of compliance with American Thyroid Association guidelines for the treatment for advanced papillary thyroid carcinoma'. Together they form a unique fingerprint.

Cite this